Protective effects of rifampicin and its analog rifampicin quinone in a mice model of obesity-induced type 2 diabetes
Published: 17 March 2022| Version 1 | DOI: 10.17632/ndmp3wg864.1
Contributors:
Arnab Mukhopadhyay, Description
Source data for the manuscript
Files
Institutions
National Institute of Immunology
Categories
Clinical Use of Antimicrobial Drugs, Rifamycins, Animal Diabetes